ink on paper
10 by 7 inches
2.23.25
#scrollwheel #geneedit #WYSIWYG #drawing #inkonpaper
ink on paper
10 by 7 inches
2.23.25
#scrollwheel #geneedit #WYSIWYG #drawing #inkonpaper
New phase 1 data on CTX310, a CRISPR-based infusion from CrisprTx, show ~50% drops in LDL & triglycerides after a single dose on top of usual therapy
biotech.industryexaminer.com/one-time-cri...
#CRISPR #GeneEdit #Biotech #Cholesterol #LDL #TechNews
New phase 1 data on CTX310, a CRISPR-based infusion from CrisprTx, show ~50% drops in LDL & triglycerides after a single dose on top of usual therapy
biotech.industryexaminer.com/one-time-cri...
#CRISPR #GeneEdit #Biotech #Cholesterol #LDL #TechNews
#CRSPR #Direwolf #ColossalBiosciences #geneedit #science #thefutureisnow
arstechnica.com/science/2025...
#CRSPR #Direwolf #ColossalBiosciences #geneedit #science #thefutureisnow
arstechnica.com/science/2025...
bit.ly/2cP9SKO
bit.ly/2cP9SKO
“Crop Improvement Using CRISPR/Cas9 Systems: Advances and Challenges“
tinyurl.com/9nhwkmt8
#WIS
#PlantandEnvironmentalSciences
#CRISPR-Cas9
#ClusteredRegularlyInterspacedShortPalindromicRepeats
#CRISPRassociatedprotein9
#ZincFingerNuclease
#GeneEdit
Fig.1
“Crop Improvement Using CRISPR/Cas9 Systems: Advances and Challenges“
tinyurl.com/9nhwkmt8
#WIS
#PlantandEnvironmentalSciences
#CRISPR-Cas9
#ClusteredRegularlyInterspacedShortPalindromicRepeats
#CRISPRassociatedprotein9
#ZincFingerNuclease
#GeneEdit
Fig.1